Free Trial

CureVac (CVAC) SEC Filings & 10K Form

CureVac logo
$5.44 -0.02 (-0.27%)
As of 12:49 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Recent CureVac SEC Filings

DateFilerForm TypeView
08/01/2025
6:10 PM
CureVac (Subject)
KfW (Filed by)
Form SCHEDULE 13D/A
06/26/2025
3:00 PM
CureVac (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
06/24/2025
3:50 PM
CureVac (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
05/07/2025
11:48 AM
CureVac (Subject)
Ramanayake Thaminda (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/10/2025
3:01 PM
CureVac (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
04/07/2025
3:01 PM
CureVac (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
03/27/2025
3:30 PM
CureVac (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
01/07/2025
4:45 PM
CureVac (Subject)
Kemula Pierre (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/07/2025
4:49 PM
CureVac (Subject)
Mendila Myriam (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/07/2025
4:40 PM
CureVac (Subject)
Zehnder Alexander (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/07/2025
4:30 PM
CureVac (Subject)
Greune Malte (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/04/2024
3:15 PM
CureVac (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
11/04/2024
3:20 PM
CureVac (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/27/2024
11:48 AM
CureVac (Subject)
Kemula Pierre (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/25/2024
1:19 PM
CureVac (Subject)
Kemula Pierre (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/12/2024
3:33 PM
CureVac (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
09/09/2024
3:15 PM
CureVac (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/15/2024
3:25 PM
CureVac (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/15/2024
3:30 PM
CureVac (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/15/2024
3:15 PM
CureVac (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
08/15/2024
3:20 PM
CureVac (Filer)
Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:CVAC) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners